Literature DB >> 26385073

Pathobiology of Helicobacter pylori-Induced Gastric Cancer.

Manuel Amieva1, Richard M Peek2.   

Abstract

Colonization of the human stomach by Helicobacter pylori and its role in causing gastric cancer is one of the richest examples of a complex relationship among human cells, microbes, and their environment. It is also a puzzle of enormous medical importance given the incidence and lethality of gastric cancer worldwide. We review recent findings that have changed how we view these relationships and affected the direction of gastric cancer research. For example, recent data have indicated that subtle mismatches between host and microbe genetic traits greatly affect the risk of gastric cancer. The ability of H pylori and its oncoprotein CagA to reprogram epithelial cells and activate properties of stemness show the sophisticated relationship between H pylori and progenitor cells in the gastric mucosa. The observation that cell-associated H pylori can colonize the gastric glands and directly affect precursor and stem cells supports these observations. The ability to mimic these interactions in human gastric organoid cultures as well as animal models will allow investigators to more fully unravel the extent of H pylori control on the renewing gastric epithelium. Finally, our realization that external environmental factors, such as dietary components and essential micronutrients, as well as the gastrointestinal microbiota, can change the balance between H pylori's activity as a commensal or a pathogen has provided direction to studies aimed at defining the full carcinogenic potential of this organism.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Gastric Cancer; H pylori; Microbiota; Stem Cells

Mesh:

Year:  2015        PMID: 26385073      PMCID: PMC4691563          DOI: 10.1053/j.gastro.2015.09.004

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  150 in total

1.  Helicobacter pylori Activates and Expands Lgr5(+) Stem Cells Through Direct Colonization of the Gastric Glands.

Authors:  Michael Sigal; Michael E Rothenberg; Catriona Y Logan; Josephine Y Lee; Ryan W Honaker; Rachel L Cooper; Ben Passarelli; Margarita Camorlinga; Donna M Bouley; Guillermo Alvarez; Roeland Nusse; Javier Torres; Manuel R Amieva
Journal:  Gastroenterology       Date:  2015-02-26       Impact factor: 22.682

2.  Grb2 is a key mediator of helicobacter pylori CagA protein activities.

Authors:  Hitomi Mimuro; Toshihiko Suzuki; Jiro Tanaka; Momoyo Asahi; Rainer Haas; Chihiro Sasakawa
Journal:  Mol Cell       Date:  2002-10       Impact factor: 17.970

Review 3.  Stem cells marked by the R-spondin receptor LGR5.

Authors:  Bon-Kyoung Koo; Hans Clevers
Journal:  Gastroenterology       Date:  2014-05-21       Impact factor: 22.682

4.  Intracellular Helicobacter pylori in gastric epithelial progenitors.

Authors:  Jung D Oh; Sherif M Karam; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

5.  Modification of Helicobacter pylori Peptidoglycan Enhances NOD1 Activation and Promotes Cancer of the Stomach.

Authors:  Giovanni Suarez; Judith Romero-Gallo; M Blanca Piazuelo; Ge Wang; Robert J Maier; Lennart S Forsberg; Parastoo Azadi; Martin A Gomez; Pelayo Correa; Richard M Peek
Journal:  Cancer Res       Date:  2015-03-02       Impact factor: 12.701

Review 6.  Helicobacter pylori VacA, a paradigm for toxin multifunctionality.

Authors:  Timothy L Cover; Steven R Blanke
Journal:  Nat Rev Microbiol       Date:  2005-04       Impact factor: 60.633

7.  Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7.

Authors:  Yinfei Yin; Anna M Grabowska; Philip A Clarke; Elisabeth Whelband; Karen Robinson; Richard H Argent; Amanda Tobias; Rajendra Kumari; John C Atherton; Susan A Watson
Journal:  Gut       Date:  2010-06-28       Impact factor: 23.059

8.  Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.

Authors:  Zhi-Xue Zheng; Yu Sun; Zhao-De Bu; Lian-Hai Zhang; Zi-Yu Li; Ai-Wen Wu; Xiao-Jiang Wu; Xiao-Hong Wang; Xiao-Jing Cheng; Xiao-Fang Xing; Hong Du; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

9.  Modelling human development and disease in pluripotent stem-cell-derived gastric organoids.

Authors:  Kyle W McCracken; Emily M Catá; Calyn M Crawford; Katie L Sinagoga; Michael Schumacher; Briana E Rockich; Yu-Hwai Tsai; Christopher N Mayhew; Jason R Spence; Yana Zavros; James M Wells
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

10.  Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population.

Authors:  Huan Song; Isabella Guncha Ekheden; Zongli Zheng; Jan Ericsson; Olof Nyrén; Weimin Ye
Journal:  BMJ       Date:  2015-07-27
View more
  223 in total

Review 1.  Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer.

Authors:  Changchang Chen; Linjie Chen; Lijun Lin; Dazhi Jin; Yaoqiang Du; Jianxin Lyu
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-26       Impact factor: 4.813

Review 2.  Diabetes, Obesity, and Breast Cancer.

Authors:  Chifei Kang; Derek LeRoith; Emily J Gallagher
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

3.  Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia.

Authors:  Matthew G Varga; Hui Cai; Tim Waterboer; Gwen Murphy; Taichi Shimazu; Phil R Taylor; You-Lin Qiao; Sue K Park; Keun-Young Yoo; Sun Ha Jee; Eo Rin Cho; Jeongseon Kim; Christian C Abnet; Shoichiro Tsugane; Qiuyin Cai; Wei Zheng; Michael Pawlita; Xiao-Ou Shu; Meira Epplein
Journal:  Dig Dis Sci       Date:  2018-06-08       Impact factor: 3.199

4.  Inhibition of polarity-regulating kinase PAR1b contributes to Helicobacter pylori inflicted DNA Double Strand Breaks in gastric cells.

Authors:  Andrea Zamperone; David Cohen; Markus Stein; Charlotte Viard; Anne Müsch
Journal:  Cell Cycle       Date:  2019-01-13       Impact factor: 4.534

5.  A peptide of a type I toxin-antitoxin system induces Helicobacter pylori morphological transformation from spiral shape to coccoids.

Authors:  Lamya El Mortaji; Alejandro Tejada-Arranz; Aline Rifflet; Ivo G Boneca; Gérard Pehau-Arnaudet; J Pablo Radicella; Stéphanie Marsin; Hilde De Reuse
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

Review 6.  Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence.

Authors:  Veronique Giroux; Anil K Rustgi
Journal:  Nat Rev Cancer       Date:  2017-09-01       Impact factor: 60.716

7.  TLR9 activation suppresses inflammation in response to Helicobacter pylori infection.

Authors:  Matthew G Varga; M Blanca Piazuelo; Judith Romero-Gallo; Alberto G Delgado; Giovanni Suarez; Morgan E Whitaker; Uma S Krishna; Rachna V Patel; Eric P Skaar; Keith T Wilson; Holly M S Algood; Richard M Peek
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-10-06       Impact factor: 4.052

8.  Tropism for Spasmolytic Polypeptide-Expressing Metaplasia Allows Helicobacter pylori to Expand Its Intragastric Niche.

Authors:  José B Sáenz; Nancy Vargas; Jason C Mills
Journal:  Gastroenterology       Date:  2018-10-01       Impact factor: 22.682

9.  Genetic Evolution of a Helicobacter pylori Acid-Sensing Histidine Kinase and Gastric Disease.

Authors:  Uma Krishna; Judith Romero-Gallo; Giovanni Suarez; Ayeetin Azah; Andrzej M Krezel; Matthew G Varga; Mark H Forsyth; Richard M Peek
Journal:  J Infect Dis       Date:  2016-05-10       Impact factor: 5.226

Review 10.  The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms.

Authors:  Kosuke Mima; Shuji Ogino; Shigeki Nakagawa; Hiroshi Sawayama; Koichi Kinoshita; Ryuichi Krashima; Takatsugu Ishimoto; Katsunori Imai; Masaaki Iwatsuki; Daisuke Hashimoto; Yoshifumi Baba; Yasuo Sakamoto; Yo-Ichi Yamashita; Naoya Yoshida; Akira Chikamoto; Takatoshi Ishiko; Hideo Baba
Journal:  Surg Oncol       Date:  2017-07-21       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.